Additive effects of CpG ODN and R-848 as adjuvants on augmenting immune responses to HBsAg vaccination
- 21 September 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 361 (2), 537-542
- https://doi.org/10.1016/j.bbrc.2007.07.028
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responsesBiochemical and Biophysical Research Communications, 2007
- Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responsesVaccine, 2006
- CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitopeVaccine, 2006
- Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligandEuropean Journal of Immunology, 2005
- CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivoVaccine, 2005
- Type I interferon dependence of plasmacytoid dendritic cell activation and migrationThe Journal of Experimental Medicine, 2005
- Adjuvant synergy in the response to hepatitis B vaccinesVaccine, 2003
- Cross-priming of CD8+ T cells stimulated by virus-induced type I interferonNature Immunology, 2003
- Interferon-α and Interleukin-12 Are Induced Differentially by Toll-like Receptor 7 Ligands in Human Blood Dendritic Cell SubsetsThe Journal of Experimental Medicine, 2002
- Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12European Journal of Immunology, 2001